DE69922594D1 - Indazol-Derivate als 5-HT1F agonists - Google Patents

Indazol-Derivate als 5-HT1F agonists

Info

Publication number
DE69922594D1
DE69922594D1 DE69922594T DE69922594T DE69922594D1 DE 69922594 D1 DE69922594 D1 DE 69922594D1 DE 69922594 T DE69922594 T DE 69922594T DE 69922594 T DE69922594 T DE 69922594T DE 69922594 D1 DE69922594 D1 DE 69922594D1
Authority
DE
Germany
Prior art keywords
indazole derivatives
ht1f agonists
ht1f
agonists
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69922594T
Other languages
English (en)
Other versions
DE69922594T2 (de
Inventor
Joseph Herman Krushinski Jr
John Mehnert Schaus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69922594D1 publication Critical patent/DE69922594D1/de
Publication of DE69922594T2 publication Critical patent/DE69922594T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69922594T 1998-07-31 1999-07-26 Indazol-Derivate als 5-HT1F agonists Expired - Fee Related DE69922594T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9494098P 1998-07-31 1998-07-31
US94940P 1998-07-31

Publications (2)

Publication Number Publication Date
DE69922594D1 true DE69922594D1 (de) 2005-01-20
DE69922594T2 DE69922594T2 (de) 2005-11-10

Family

ID=22248060

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69922594T Expired - Fee Related DE69922594T2 (de) 1998-07-31 1999-07-26 Indazol-Derivate als 5-HT1F agonists

Country Status (6)

Country Link
US (1) US6133290A (de)
EP (1) EP0978514B1 (de)
AT (1) ATE284879T1 (de)
AU (1) AU4696199A (de)
DE (1) DE69922594T2 (de)
WO (1) WO2000006173A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696439B1 (en) * 1999-02-26 2004-02-24 Eli Lilly And Company 5-HT1F agonists
CA2440842A1 (en) * 2001-04-16 2002-10-24 Eisai Co., Ltd. Novel 1h-indazole compounds
EP1403255A4 (de) 2001-06-12 2005-04-06 Sumitomo Pharma Rho-kinase-inhibitoren
GB0203811D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
ES2388547T3 (es) * 2003-04-18 2012-10-16 Eli Lilly And Company Compuestos de (piperidiniloxi)fenilo, (piperidiniloxi)piridinilo, (piperidinilsulfanil)fenilo y (piperidinilsulfanil)piridinilo como agonistas de 5-HT 1F
EP1676841A1 (de) * 2004-12-30 2006-07-05 Esteve Laboratorios Dr. Esteve S.A. Substituierte Indazolsulfonamid- und 2,3-Dihydroindolyl-Sulfonamidverbindungen, deren Herstellung und Verwendung in Medikamenten
EP2487159A1 (de) 2011-02-11 2012-08-15 MSD Oss B.V. RORgammaT-Hemmer
WO2014026330A1 (en) * 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
WO2014026329A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
WO2014026327A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
EP3256450B1 (de) 2015-02-11 2020-12-02 Merck Sharp & Dohme Corp. Substituierte pyrazolverbindungen als ror-gamma-t-inhibitoren und verwendungen davon
JP2018531957A (ja) 2015-10-27 2018-11-01 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． ＲＯＲγＴ阻害薬としての置換二環式ピラゾール化合物及びその使用
WO2017075182A1 (en) 2015-10-27 2017-05-04 Merck Sharp & Dohme Corp. Substituted indazole compounds as rorgammat inhibitors and uses thereof
EP3368535B1 (de) 2015-10-27 2020-12-02 Merck Sharp & Dohme Corp. Heteroaryl-substituierte benzoesäuren als ror-gamma-t-hemmer und verwendungen davon
AU2019323450A1 (en) 2018-08-24 2021-02-11 Sunshine Lake Pharma Co., Ltd. Pyridinylmethylenepiperidine derivatives and uses thereof
MX2021015996A (es) * 2019-07-11 2022-06-08 Escape Bio Inc Indazoles y azaindazoles como inhibidores de cinasa de repetición rica en leucina 2 (lrrk2).

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU198036B (en) * 1983-08-22 1989-07-28 Hoechst Roussel Pharma Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
EP0494774A1 (de) * 1991-01-11 1992-07-15 MERCK SHARP & DOHME LTD. Indazol-substituierte 5-Kettenglieder heteroaromatische Verbindungen
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
DK60793D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
CN1184425A (zh) * 1995-03-20 1998-06-10 伊莱利利公司 5－取代－3－(1,2,3,6－四氢吡啶－4－基)－和3－(哌啶－4－基)－1h－吲哚:新型5－ht1f激动剂
WO1997049698A1 (en) * 1996-06-21 1997-12-31 Glaxo Group Limited Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
WO1998015545A1 (en) * 1996-10-08 1998-04-16 Eli Lilly And Company New serotonin 5-ht1f agonists
ZA979961B (en) * 1996-11-15 1999-05-05 Lilly Co Eli 5-HT1F agonists
EP0875513A1 (de) * 1997-04-14 1998-11-04 Eli Lilly And Company Substituierte heteroaromatische 5-HT1F Agoniste

Also Published As

Publication number Publication date
DE69922594T2 (de) 2005-11-10
EP0978514B1 (de) 2004-12-15
EP0978514A1 (de) 2000-02-09
US6133290A (en) 2000-10-17
AU4696199A (en) 2000-02-21
WO2000006173A8 (en) 2000-04-06
WO2000006173A1 (en) 2000-02-10
ATE284879T1 (de) 2005-01-15

Similar Documents

Publication Publication Date Title
ATE252572T1 (de) 5-ht1f agonisten
ATE284879T1 (de) Indazol-derivate als 5-ht1f agonists
DK1004578T3 (da) 5-oxo-pyrrolidin-2-carboxylsyrehydroxamidderivater
DE60036924D1 (de) 5-ht1f agonisten
DE69615674T2 (de) Cyclobutan-derivate als inhibitoren der squalen-synthase und der protein farnesyltransferase
CY1112024T1 (el) Αναστολεις υποδοχεων adp αιμοπεταλιων
DE60032780D1 (de) Tetrahydroquinolin-derivate
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
EA200100203A1 (ru) Производные 4,4-биарилпиперидина с активностью в отношении опиоидных рецепторов
MXPA05000708A (es) Derivados de quinolina 8-hidroxi.
EA200500814A1 (ru) Производные пирролопиримидина
ES2191260T3 (es) Derivados de la imidazolidin-4-ona utiles como agentes anticancerosos.
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
NO985518D0 (no) Morfinanderivater og medisinsk anvendelse derav
PE20011085A1 (es) Compuestos isoxazolquinolin o imidazolquinolin como inhibidores de la proteina resistente a multifarmacos
EP1101755A4 (de) Anthranilsäurederivate
WO2000000490A3 (en) 5-ht1f agonists
DK0952159T3 (da) Anvendelse af phenylhydrazonderivater som antiinflammatoriske eller analgetiske midler
EA200100918A1 (ru) Агонисты 5-ht1f рецептора
TR200103562T2 (tr) Amiloid proteini toplanmasını önleme ve amiloid birikintilerini görüntüleme yönteminde kullanım için rodanin türevleri
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.
DK0810223T3 (da) Adamantylsubstituerede oxindoler som farmaceutiske midler
BR9604914A (pt) Inibidores de agregaçao de plaquetas contendo resíduos de aminoácido de cadeia lateral aminérgicos c-terminais
BR0013168A (pt) Compostos de pseudomicina modificados com amina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee